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Abstract It is of great clinical importance to identify simple
prognostic markers from preoperative biopsies that could guide
treatment planning. Here, we compared tumor budding (B),
depth of invasion (D), and the combined scores (i.e., budding
and depth of invasion (BD) histopathologic model) in preoper-
ative biopsies and the corresponding postoperative specimens
of oral tongue squamous cell carcinoma (OTSCC). Tumor bud-
ding and depth of invasion were evaluated in the pre- and post-
operative samples from 100 patients treated for OTSCC.
Sensitivity and specificity statistics were used. Our results
showed statistically significant (P < 0.001) relationship be-
tween pre- and postoperative BD scores. There was an agree-
ment between the pre- and postoperative BDmodel scores in 83
cases (83%)with 57.1% sensitivity (95%CI 39.4 to 73.7%) and
96.9% specificity (95% CI 89.3 to 99.6%). Our findings sug-
gest that the BD model, analyzed from representative biopsies,
could be used for the treatment planning of OTSCC.
Keywords Oral tongue cancer . Tumor budding . Tumor
depth . BDmodel . Prognosis
Introduction
Oral or mobile tongue squamous cell carcinoma (OTSCC) has
shown increased incidence in several countries [1].
Aggressive behavior and poor prognosis are reported even at
early stages of the tumor [2, 3]. A preoperative biopsy is
routinely obtained for histopathologic diagnosis of suspicious
tongue lesions. Although several prognostic markers for
OTSCC have been published, there is still a lack of validated
markers that could easily be evaluated in preoperative OTSCC
histological sections. Therefore, identification of prognostic
marker(s) in biopsy specimens would be a valuable tool for
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treatment planning (local resection with or without the neck
dissection).
We have previously introduced the budding and depth
(BD) histopathologic model as a prognostic tool in OTSCC
[4]. The prognostic value of this model has been validated in
cohorts of oral squamous cell carcinomas (OSCC) [5, 6]. In
these studies, the BDmodel was shown to have superior prog-
nostic power when compared to the other previously intro-
duced histopathologic grading systems, such asWHO grading
[7], malignancy grading of the deep invasive margins [8], and
histological risk score [9]. Additionally, tumor budding is as-
sociated with the progression and prognosis of several epithe-
lial cancers, such as head and neck [10], esophageal [11],
colorectal [12], pancreatic [13], lung [14], and breast [15].
Specifically in OTSCC, budding correlates with occult cervi-
cal lymph node metastasis and poor prognosis [16, 17].
Similarly, the depth of invasion is a prognostic marker for
OTSCC [17]. Recently, pre- and postoperative samples were
compared in a study of 91 OSCC cases, and it was shown that
both budding and tumor depth correlated significantly with
relapse-free survival [18]. To our knowledge, however, there
is no sizeable cohort where the BD model has been tested in
OTSCC biopsies and compared to the corresponding postop-
erative OTSCC samples. The aim of this study was to analyze
the sensitivity and specificity of preoperative BD scores of
hematoxylin and eosin-stained OTSCC biopsies compared
to the postoperative BD scores of the corresponding cases.
Material and methods
Hematoxylin and eosin (HE)-stained slides from pre- and
postoperative samples of 145 patients diagnosed with
OTSCC at the University Hospitals of Helsinki, Kuopio, and
Oulu between the years 1981 and 2016 were retrieved for this
study. The use of pre- and postoperative samples and the data
inquiry was approved by the ethics committees of Helsinki,
Kuopio, and Oulu University Hospitals. All patients were di-
agnosed by incisional biopsy and treated by surgical excision
of the tumor. Patients without either pre- or postoperative
counterparts available were excluded. Cases received preop-
erative therapy were also excluded. A total of 100 cases were
eligible for the comparative analyses.
Tumor budding (B) was defined as the presence of single
cancer cell or cluster of less than five cancer cells. The inva-
sive front (IF) was evaluated under low magnification (×4),
and then, the field with the highest density of tumor budding
was counted under high magnification (×20). The depth of
tumor invasion (D) was measured from the surface of the
tumor to the deepest point of invasion. The scoring was per-
formed by an independent researcher (AA) and reviewed by
an experienced head and neck pathologist (IL). BD scores
were assigned as previously described [4] (Fig. 1). In brief,
score 0 refers to < 5 buds at the IF and < 4 mm in depth. Score
1 refers to either presence of ≥ 5 buds at the IF or a deep tumor
of ≥ 4 mm in depth. Score 2 refers to the presence of ≥ 5 buds
at the IF and a deep tumor of ≥ 4 mm in depth.
Statistical analysis All analyses were performed with IBM
SPSS version 20. The statistical significance of the relation-
ship between pre- and postoperative measures was evaluated
using chi-square test. For sensitivity and specificity statistics
with their 95% confidence intervals (95% CI), BD scores of
low and intermediate were combined together (low and inter-
mediate vs. high) to evaluate the predictive power of preoper-
ative score for the postoperative score of the corresponding
sample.
Results
Patient characteristics
One case received preoperative therapy and was therefore ex-
cluded from our analysis. A total of 100 patients were enrolled
in the statistical analyses of the study. There were 51 males
(51.0%). Stage distribution was as follows: 41 cases (41.0%)
were assigned as stage I, 40 (40.0%) as stage II, 9 (9.0%) as
stage III, and 10 (10.0%) as stage IV. The mean age at diag-
nosis was 60.8 years (range 27 to 91 years). All tumors were
located on the oral tongue (OTSCC).
Histopathologic correlation between biopsy specimens
and surgical resection specimens
Tumor budding
The number of tumor budding in biopsies ranged from 0
to 13 buds (median 1, mean 3.5), and that for the corre-
sponding postoperative samples ranged from 0 to 17 buds
(median 3, mean 3.9). Of the cases, 82 (82%) had the
same B category (low < 5 buds or high ≥ 5 buds) in the
pre- and postoperative samples. The association between
pre- and postoperative B was statistically significant (P
value of chi-square test < 0.001). The preoperative scores
showed a good sensitivity of 59.1% (95% CI 43.3 to
73.7%) and a high specificity of 100% (95% CI 93.6 to
100%) in predicting the postoperative score of the same
case (Table 1).
Depth of invasion
In biopsy specimens, depth values ranged from 0.5 to
10 mm (mean 4.1 mm, median 4 mm), and those for the
corresponding postoperative samples ranged from 0.5 to
23 mm (mean 6.3 mm, median 6 mm). Of the cases, 77
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(77.0%) had the same D category (superficial < 4 mm or
deep ≥ 4 mm) in the pre- and postoperative samples. The
relationship between the pre- and postoperative D value
was statistically significant (P value of chi-square test
< 0.001). The preoperative measurement showed a high
predictive power of postoperative measurement with
77.1% sensitivity (65.6 to 86.3%) and 76.7% specificity
(57.2 to 90.1%) (Table 1).
Table 1 Distribution of cases
according to preoperative and
postoperative scores
Postoperative budding Total n (%)
Preoperative budding Low n (%) High n (%)
• Low 56 (75.7) 18 (24.3) 74 (100)
• High 0 26 (100) 26 (100)
Postoperative depth
Preoperative depth Superficial n (%) Deep n (%)
• Superficial 23 (59.0) 16 (41.0) 39 (100)
• Deep 7 (11.5) 54 (88.5) 61 (100)
Postoperative BD score
Preoperative BD score Low or intermediate n (%) High n (%)
• Low or intermediate 63 (80.8) 15 (19.2) 78 (100)
• High 2 (9.1) 20 (90.9) 22 (100)
Fig. 1 Score 0 (a–d): Small magnification of preoperative biopsy (a) of
superficial tumor without tumor budding in the higher magnification (b)
of the IF. Small magnification for the corresponding resection specimen
(c), and higher magnification of the IF (d). Score 1 (e–h): Small
magnification of preoperative biopsy of very deep tumor (e), without
tumor budding at the invasive front (f). Small magnification of the
corresponding resection specimen (g) and higher magnification of the
IF (h) which shows no tumor budding. Score 2 (i–l): Small
magnification of preoperative biopsy of very deep tumor (i), with the
presence of tumor budding at the IF in the higher magnification (j).
Small magnification of the corresponding resection specimen (k) and
higher magnification of the IF (l) which shows tumor budding. IF
invasive front. Small magnification, ×20. Higher magnification, ×100
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BD model
For the preoperative samples, 35 cases (34.7%) had BD score
0, 43 cases (42.6%) had score 1, and 23 cases (22.8%) had
score 2. In the postoperative samples, 21 cases (20.8%) had
score 0, 44 cases (43.6%) had score 1, and 36 cases (35.6%)
had score 2. There was a significant association between
scores of BD model and cTNM stage (two-sided P = 0.001).
The BD histological model showed a highly significant rela-
tionship between pre- and postoperative measurements (P val-
ue of chi-square test < 0.001). There was an agreement be-
tween the pre- and postoperative scores of the BDmodel in 83
cases (83.0%) with 57.1% sensitivity (95% CI 39.4 to 73.7%)
and 96.9% specificity (95% CI 89.3 to 99.6%) (Table 1).
Discussion
During the histopathologic evaluation of OTSCC, patholo-
gists attempt to identify histopathological prognostic markers.
Identification of such markers, especially in early-stage tu-
mors, could guide clinical treatment decisions. Recently, our
group suggested the BD model as a prognostic tool in a large
multicenter cohort of OTSCC [4]. This model is now also
validated in other cohorts of OSCC [5, 6]. In the multivariate
analysis of these previous studies, BD model showed superior
prognostic power compared to the other parameters. In this
study, we demonstrated a significant relationship between the
BD scores in the pre- and postoperative OTSCC samples. This
finding is particularly useful for making treatment decisions at
an early stage, but occasionally highly aggressively behaving
cases. The use of BD model in daily practice might provide a
reliable additional prognostic tool that could overcome the
shortcoming of currently used preoperative tumor size staging
(T) and histopathological biopsy grading. Both of these com-
monly used preoperative analyses, tumor clinical size mea-
surement and cancer cell differentiation grading, have been
criticized for their low prognostic power of the cancer [2, 19].
Cancer cell can invade individually or in a collection of cell
clusters [20]. Different patterns for head and neck cancers
invasion have been suggested, including worst pattern of in-
vasion (WPOI) and tumor budding. WPOI was introduced as
a part of histologic risk model [21], and it was shown as a
useful prognostic marker in early OTSCC [2]. However, tu-
mor satellites, which represent type 5 WPOI and are defined
as tumor island/s located 1 mm or more away from the main
tumor or next closest satellite, require the evaluation of all
tumor sections [21], and thus, this score remains inapplicable
for biopsy specimen analyses. On the other hand, tumor bud-
ding is a recently introduced histopathologic pattern which
has been reported as a promising prognosticator in several
carcinomas [10–13, 15] and has been successfully evaluated
in preoperative biopsy [18, 22]. A five-bud cutoff point has
widely been used in OSCC [17, 23–25] and other cancers [26,
27] to stratify the tumors into low-risk (< 5 buds) or high-risk
groups (≥ 5 buds).
Depth of invasion has been reported as a significant prog-
nosticator in OTSCC [17, 28, 29]. The cutoff point of 4-mm
depth is widely accepted and has been validated in recent
OTSCC studies [2, 30, 31]. Of note, a meta-analysis has also
concluded that 4 mmwould be an optimal cutoff point [32]. In
this study, we found a good correlation between the depth in
the preoperative and postoperative samples when we stratified
the cases into two categories (superficial < 4 mm vs. deep
≥ 4 mm). However, when the exact measurements (i.e., quan-
titative) of pre- and postoperative depth were compared, the
correlations were low. This was expected as in the postopera-
tive samples, the measurement could be taken at several sites
of the cancer sections, while in the preoperative biopsies, the
measurement is possible only from a limited tumor area. More
importantly, in the present series, both measurements were in
the same category (superficial < 4 mm or deep ≥ 4 mm) in
77% of the cases. For the remaining cases, low-quality biop-
sies (e.g., superficial samples missing the deepest part of the
tumor) did not allow accurate measurement of the invasion
depth. The validity of preoperative tumor depth evaluation
by ultrasonography or magnetic resonance imaging (or both)
has been confirmed in many studies [33–36]. This should be
considered as a surrogate method in case the entire tumor
thickness is unclear in the preoperative biopsy. Additionally,
the depth of invasion evaluation from fresh-frozen intraoper-
ative sections has shown a strong association with the postop-
erative measurement [37]. Such procedures could also reduce
the inaccuracy in the preoperative biopsy measurement.
Similar to our multicenter Finnish study of 100 OTSCC
patients, a Japanese group has recently published a study of
91 OSCC cases from tongue and floor of mouth [18]. They
concluded that the budding scores in particular showed a sig-
nificant correlation between biopsies and corresponding
resected specimens. Such a correlation was also observedwith
the depth measurements, but with less accuracy. These two
separate cohorts both highlight the usefulness of preoperative
evaluation of the budding and in cases of representative, suf-
ficiently deep biopsies, also, the depth of invasion. Of note,
the results of our current study are based on SCC cases from
themobile tongue only, a subsite of oral cavity, in which SCCs
are mostly human papilloma virus (HPV) negative [38, 39]. In
contrast, HPV-positive head and neck SCCs most commonly
occur in the oropharynx (including base of the tongue) and are
reported to have a favorable prognosis [40].
All our cases that had different scores (about 17%) in the
BDmodel in the preoperative compared to postoperative sam-
ples had non-representative biopsies. These biopsies were of-
ten badly fragmented and too superficial, or had some techni-
cal artifacts, such as tangential cutting. Therefore, we strongly
recommend that clinicians carefully take a large (at least 4 mm
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wide and 4 mm deep) biopsy (or several biopsies from differ-
ent parts of the tumor) that includes the deepest part of the
tumor. A high-quality biopsy would allow the pathologist to
evaluate the BD model accurately. However, if the quality of
the biopsy is low (too shallow, fragmented, or not in the
deepest area), the BD model evaluation would be inadequate.
Several previous findings have shown that the BDmodel is
a simple and predictive histopathological grading system for
OSCC patients [4–6, 18]. Here, we demonstrated that in sat-
isfactory biopsies, the BD model can be evaluated from HE-
stained slides, and the BD scores significantly corresponded to
the scores of postoperative tumor resection samples.
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